Letter to the Editor From Hao and Xue: “Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”-Reference-Cited by-同舟云学术

Letter to the Editor From Hao and Xue: “Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”

Published:2024-08-16 Issue: Volume: Page:
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Hao Lu¹^ORCID,Xue Jisu²^ORCID

Affiliation:

1. Science and Education Department, Shenzhen Baoan Shiyan People's Hospital , Shenzhen 518000 , China

2. Department of Endocrinology, Shenzhen Baoan Shiyan People's Hospital , Shenzhen 518000 , China

Funder

Health and Medical Scientific Research Project of Shenzhen Bao’an Medical Association

Publisher

The Endocrine Society

Link

https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgae554/58935527/dgae554.pdf

Reference5 articles.

1. Checkpoint inhibitor-associated autoimmune diabetes mellitus is characterized by c-peptide loss and pancreatic atrophy;Wu;J Clin Endocrinol Metab,2024

2. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update;Schneider;J Clin Oncol,2021

3. New-onset diabetes in Covid-19;Rubino;N Engl J Med,2020

4. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment;Wu;Cell Metab,2021

5. Glucocorticoid-induced diabetes mellitus: an important but overlooked problem;Suh;Endocrinol Metab (Seoul),2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Letter to the Editor from Hao and Xue: “Checkpoint Inhibitor-associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”;The Journal of Clinical Endocrinology & Metabolism;2024-08-13